V Nissapatorn, Y Anis, R V Labana, D Mendonça, S Ayunee, R V D Dimasin, R Bodade, S Sukati, R Boonhok, S M R Oliveira, A P Girol, M de Lourdes Pereira, L Chooi-Ling, C Samudi
Journal: Tropical biomedicine 2025;42(2):169-183
PMID: 40618363
Garcinia mangostana is a tropical tree native to India, Sri Lanka, and Southeast Asia. In Traditional Medicinal Systems (TMS), decoctions and infusions prepared from mangosteen fruits have effectively treated skin lesions and various inflammatory conditions. Researchers have also reported its extensive biological activities, viz. antimicrobial, antioxidant, anticancer, antidiabetic, neuroprotective, and cardioprotective effects. This literature review comprehensively describes the biological potential of G. mangostana over the last twenty-five years. It includes a discussion of the bioactive compounds of G. mangostana and their extraction, purification, and characterization processes. Antimicrobial, anticancer, antitumorigenic, antidiabetic, anti-inflammatory, neuroprotective, and antiparasitic activities are discussed in detail. Furthermore, the paper addresses the main obstacles associated with using mangosteen extracts and suggests ways to overcome these challenges. The medicinal properties of G. mangostana are primarily attributed to a-mangostin and other bioactive xanthones. However, other bioactive compounds with potential therapeutic activities remain not fully characterized. Therefore, developing effective extraction methods for these bioactive compounds, along with their characterization, possible bioactivities (pharmacodynamics), and any synergistic effects, is essential. Additionally, pharmacokinetic studies, including absorption, distribution, metabolism, excretion, and toxicity (ADMET), are necessary. It is also worth considering plant parts other than the pericarp.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.